Flamand; Louis
Patent Applications and Registrations
Patent applications and USPTO patent grants for Flamand; Louis.The latest application filed is for "recombinant human cc10 protein for treatment of influenza".
- Flamand; Louis - Quebec N/A CA
- Flamand; Louis - Sainte-Foy CA
| Patent | Date |
|---|---|
| Recombinant human CC10 protein for treatment of influenza Grant 8,957,018 - Pilon , et al. February 17, 2 | 2015-02-17 |
| Recombinant Human Cc10 Protein For Treatment Of Influenza App 20120231997 - Pilon; Aprile L ; et al. | 2012-09-13 |
| LTB.sub.4 as vaccine adjuvant Grant 7,914,800 - Flamand , et al. March 29, 2 | 2011-03-29 |
| In vivo release of endogenous anti-microbial mediators by leukotriene B4 (LTB4) administration App 20050239889 - Gosselin, Jean ; et al. | 2005-10-27 |
| Ltb4 as vaccine adjuvant App 20040208882 - Flamand, Louis ; et al. | 2004-10-21 |
| Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs App 20040131701 - Gosselin, Jean ; et al. | 2004-07-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 